NYSE:PBH Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis $49.48 +1.56 (+3.26%) Closing price 03:59 PM EasternExtended Trading$49.48 +0.01 (+0.01%) As of 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Prestige Consumer Healthcare Stock (NYSE:PBH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PBH alerts:Sign Up Key Stats Today's Range$47.50▼$49.6450-Day Range$44.68▼$52.9152-Week Range$42.62▼$71.07Volume660,900 shsAverage Volume562,398 shsMarket Capitalization$2.34 billionP/E Ratio13.86Dividend YieldN/APrice Target$67.67Consensus RatingHold Company Overview Prestige Consumer Healthcare Inc. (NYSE: PBH) is a consumer healthcare company that develops, acquires, markets and distributes over-the-counter health and wellness products. Its portfolio is focused on established brands designed to address everyday healthcare needs, including digestive health, eye and ear care, oral care, pain relief, cold and allergy symptoms, feminine care and dermatological conditions. The company's brands include Dramamine and Bonine for motion-sickness relief; BC and Goody's for pain relief; Clear Eyes and Murine for eye and ear care; Chloraseptic for sore-throat relief; Compound W for wart removal; Fleet for gastrointestinal health; and Summer's Eve for feminine care. Prestige also markets other consumer healthcare products through retail, drugstore, grocery, mass-merchandise, e-commerce and healthcare channels. Prestige Consumer Healthcare was established in 1996 and is headquartered in Tarrytown, New York. The company primarily serves consumers in the United States and Canada, while also selling selected products in international markets. Its strategy centers on managing a portfolio of recognizable, nonprescription healthcare brands and supporting their distribution, marketing and product development.AI Generated. May Contain Errors. Read More Prestige Consumer Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScorePBH MarketRank™: 3.864148442675 of 5 starsPrestige Consumer Healthcare scored higher than 77% of companies evaluated by MarketBeat, and ranked 146th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingPrestige Consumer Healthcare has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and 1 sell rating.Upside PotentialPrestige Consumer Healthcare has a consensus price target of $67.67, representing about 37.1% upside from its current price of $49.35.Amount of Analyst CoveragePrestige Consumer Healthcare has only been the subject of 2 research reports in the past 90 days.Read more about Prestige Consumer Healthcare's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth11.62% Earnings GrowthEarnings for Prestige Consumer Healthcare are expected to grow by 11.62% in the coming year, from $4.56 to $5.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Prestige Consumer Healthcare is 13.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.71.Price to Earnings Ratio vs. SectorThe P/E ratio of Prestige Consumer Healthcare is 13.82, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.18.Price to Earnings Growth RatioPrestige Consumer Healthcare has a PEG Ratio of 1.55. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrestige Consumer Healthcare has a P/B Ratio of 1.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Prestige Consumer Healthcare's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.95% of the float of Prestige Consumer Healthcare has been sold short.Short Interest Ratio / Days to CoverPrestige Consumer Healthcare has a short interest ratio ("days to cover") of 6.6.Change versus previous monthShort interest in Prestige Consumer Healthcare has recently decreased by 3.12%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldPrestige Consumer Healthcare does not currently pay a dividend.Dividend GrowthPrestige Consumer Healthcare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Prestige Consumer Healthcare is 53.22%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Prestige Consumer Healthcare will have a dividend payout ratio of 37.33% next year. This indicates that Prestige Consumer Healthcare will be able to sustain or increase its dividend.Read more about Prestige Consumer Healthcare's dividend. News and Social Media2.2 / 5News Sentiment0.53 News SentimentPrestige Consumer Healthcare has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Prestige Consumer Healthcare this week, compared to 3 articles on an average week.Search Interest7 people have searched for PBH on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock.Percentage Held by Insiders1.50% of the stock of Prestige Consumer Healthcare is held by insiders.Percentage Held by Institutions99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Prestige Consumer Healthcare's insider trading history. Receive PBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PBH Stock News HeadlinesContrasting Prestige Consumer Healthcare (NYSE:PBH) and RYTHM (NASDAQ:RYM)October 19 at 5:28 AM | americanbankingnews.comIs it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?October 15, 2026 | uk.finance.yahoo.comFederal Reserve’s Disturbing Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.October 22 at 1:00 AM | Weiss Ratings (Ad)Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings ResultsOctober 14, 2026 | globenewswire.comMore Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey FindsSeptember 30, 2026 | prnewswire.comHas Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings?September 29, 2026 | finance.yahoo.comPrestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 TargetsSeptember 29, 2026 | finance.yahoo.comPrestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference TranscriptSeptember 10, 2026 | seekingalpha.comSee More Headlines PBH Stock Analysis - Frequently Asked Questions How have PBH shares performed this year? Prestige Consumer Healthcare's stock was trading at $61.69 at the beginning of 2026. Since then, PBH shares have decreased by 20.0% and is now trading at $49.35. How were Prestige Consumer Healthcare's earnings last quarter? Prestige Consumer Healthcare Inc. (NYSE:PBH) released its quarterly earnings data on Thursday, August, 6th. The company reported $0.98 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.09. The business's quarterly revenue was up 6.5% compared to the same quarter last year. Read the conference call transcript. Who are Prestige Consumer Healthcare's major shareholders? Top institutional shareholders of Prestige Consumer Healthcare include Congress Asset Management Co. (0.35%), Milestone Asset Management LLC (0.06%), Pinnacle Associates Ltd. (0.05%) and State of Alaska Department of Revenue (0.02%). Insiders that own company stock include Ronald M Lombardi, Jeffrey Zerillo, William P'pool, Adel Mekhail and Mary Beth Fritz. View institutional ownership trends. How do I buy shares of Prestige Consumer Healthcare? Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Prestige Consumer Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include Boeing (BA), NVIDIA (NVDA), Visa (V), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS) and GE Aerospace (GE). Company Calendar Last Earnings8/06/2026Today10/22/2026Next Earnings (Estimated)11/05/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1d) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 PBH's financial health is in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:PBH CIK1295947 Webwww.prestigebrands.com Phone(914) 524-6800Fax302-674-5266Employees890Year Founded1996Price Target and Rating Average Price Target for Prestige Consumer Healthcare$67.67 High Price Target$72.00 Low Price Target$65.00 Potential Upside/Downside+36.8%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$3.57 Trailing P/E Ratio13.86 Forward P/E Ratio10.85 P/E Growth1.55Net Income$190.30 million Net Margins15.57% Pretax Margin21.20% Return on Equity11.39% Return on Assets5.66% Debt Debt-to-Equity Ratio1.06 Current Ratio3.23 Quick Ratio1.99 Sales & Book Value Annual Sales$1.10 billion Price / Sales2.12 Cash Flow$5.22 per share Price / Cash Flow9.48 Book Value$39.89 per share Price / Book1.24Miscellaneous Outstanding Shares47,375,000Free Float46,664,000Market Cap$2.34 billion OptionableOptionable Beta0.34 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NYSE:PBH) was last updated on 10/22/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
